{"filing":{"accession_number":"0001493152-26-027132","cik":"0001752828","ticker":"CELUW","company_name":"Celularity Inc","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315226027132/form8-k.htm"},"events":[{"id":7260,"run_id":6374,"accession_number":"0001493152-26-027132","anchor_item_number":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Rick Gonzalez as Chief Commercial Officer of Celularity Inc., effective May 29, 2026, reporting directly to the CEO. This is a material executive appointment that would affect investor assessment of the company's leadership and commercial strategy, particularly given the emphasis in the shareholder letter on commercial opportunities for cenplacel-L and the Lifebank platform.","company_name":"Celularity Inc","ticker":"CELUW","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":4089,"accession_number":"0001493152-26-027132","item_number":null,"item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Rick Gonzalez as Chief Commercial Officer of Celularity Inc., effective May 29, 2026, reporting directly to the CEO. This is a material executive appointment that would affect investor assessment of the company's leadership and commercial strategy, particularly given the emphasis in the shareholder letter on commercial opportunities for cenplacel-L and the Lifebank platform.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:46:59.269334+00:00","company_name":"Celularity Inc","ticker":"CELUW","filing_date":"2026-06-03"}]}